PT785787E - Utilizacao de derivados de 1,5-benzodiazepina para o controlo de esvaziamento gastrico em doentes com diabetes mellitus nao-insulino dependentes - Google Patents

Utilizacao de derivados de 1,5-benzodiazepina para o controlo de esvaziamento gastrico em doentes com diabetes mellitus nao-insulino dependentes

Info

Publication number
PT785787E
PT785787E PT95935280T PT95935280T PT785787E PT 785787 E PT785787 E PT 785787E PT 95935280 T PT95935280 T PT 95935280T PT 95935280 T PT95935280 T PT 95935280T PT 785787 E PT785787 E PT 785787E
Authority
PT
Portugal
Prior art keywords
nao
employment
gastric
patients
insulin dependent
Prior art date
Application number
PT95935280T
Other languages
English (en)
Inventor
Rochelle Hanley
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Publication of PT785787E publication Critical patent/PT785787E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
PT95935280T 1994-10-14 1995-10-13 Utilizacao de derivados de 1,5-benzodiazepina para o controlo de esvaziamento gastrico em doentes com diabetes mellitus nao-insulino dependentes PT785787E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9420747A GB9420747D0 (en) 1994-10-14 1994-10-14 1,5 benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
PT785787E true PT785787E (pt) 2002-04-29

Family

ID=10762854

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95935280T PT785787E (pt) 1994-10-14 1995-10-13 Utilizacao de derivados de 1,5-benzodiazepina para o controlo de esvaziamento gastrico em doentes com diabetes mellitus nao-insulino dependentes

Country Status (10)

Country Link
EP (1) EP0785787B1 (pt)
JP (1) JPH10511931A (pt)
AT (1) ATE210446T1 (pt)
AU (1) AU3736195A (pt)
DE (1) DE69524622T2 (pt)
DK (1) DK0785787T3 (pt)
ES (1) ES2166406T3 (pt)
GB (1) GB9420747D0 (pt)
PT (1) PT785787E (pt)
WO (1) WO1996011691A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750353A (en) * 1995-12-11 1998-05-12 New England Medical Center Hospitals, Inc. Assay for non-peptide agonists to peptide hormone receptors
IL124808A0 (en) 1995-12-11 1999-01-26 New England Medical Center Inc Assay for and uses of peptide hormone receptor ligands
CA2347938A1 (en) * 1998-10-20 2000-04-27 Takahiro Matsumoto 1,5-benzodiazepine compounds, their production and use
US9815850B2 (en) 2016-02-05 2017-11-14 Denali Therapeutics Inc. Compounds, compositions and methods
PL3552017T3 (pl) 2016-12-09 2022-08-08 Denali Therapeutics Inc. Związki użyteczne jako inhibitory RIPK1
WO2021071837A1 (en) 2019-10-07 2021-04-15 Kallyope, Inc. Gpr119 agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187154A (en) * 1990-12-13 1993-02-16 Board Of Regents, The University Of Texas System Diagnosis and treatment of humans with diabetes or at risk to develop diabetes
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin

Also Published As

Publication number Publication date
GB9420747D0 (en) 1994-11-30
ES2166406T3 (es) 2002-04-16
WO1996011691A1 (en) 1996-04-25
DE69524622D1 (de) 2002-01-24
DK0785787T3 (da) 2002-03-11
DE69524622T2 (de) 2002-08-08
AU3736195A (en) 1996-05-06
JPH10511931A (ja) 1998-11-17
EP0785787A1 (en) 1997-07-30
EP0785787B1 (en) 2001-12-12
ATE210446T1 (de) 2001-12-15

Similar Documents

Publication Publication Date Title
DK0773226T3 (da) Propiophenonderivater og fremgangsmåder til fremstilling deraf
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
CA2329004A1 (en) Combination of insulin sensitizer with anorectic for treating or preventing diabetes
GT199900158A (es) "combinaciones para la diabetes"
ES545330A0 (es) Un procedimiento para preparar derivados de 1,3-difosfonato
ES2032896T3 (es) Procedimiento para la preparacion de cristales mixtos a base de insulina y derivados de insulina.
BR9610481A (pt) Agonistas adrenérgicos beta seletivos
PT785787E (pt) Utilizacao de derivados de 1,5-benzodiazepina para o controlo de esvaziamento gastrico em doentes com diabetes mellitus nao-insulino dependentes
ES2163531T3 (es) Carboxilatos de aminoguanidina para el tratamiento de diabetes mellitus no insulinodependiente.
EP0424156A3 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
KR930701170A (ko) 항당뇨병약품
EA199900881A1 (ru) Терапевтическое средство против сахарного диабета
EP1121932A4 (en) DRUGS FOR EYE DISEASES
CA2030346A1 (en) Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
ES2181923T3 (es) 4-hidroxicumarin-3-carboxamidas para el tratamiento de la diabet es mellitus no dependiente de la insulina.
FI955829A0 (fi) Heterosyklinen kemia
AU691674B2 (en) Preventive and remedy for diarrhea
TR199501115A2 (tr) Cift cevrimli oksazol ve tiyazol ikameli eterler.
PL348152A1 (en) Use of benzoylguanidines for the treatment of non-insulin-dependent diabetes mellitus
CA2236269A1 (en) Selective .beta.3 adrenergic agonists
ES1004491Y (es) Horma para el tratamiento ortopedico de calzado.
IT1245631B (it) Impiego di composti macrolidi come agenti anti-infiammatori per il trattamento di malattie provocate da cessione di istamina